Advisor Partners II’s Pfizer PFE Stock Holding History

Advisor Partners II’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$7.02M	Sell	211,624 -8,122	-4%	-$287K	0.28%	54
2023 Q2	$8.06M	Buy	219,746 +16,076	+8%	+$626K	0.38%	45
2023 Q1	$8.31M	Sell	203,670 -39,561	-16%	-$1.71M	0.46%	37
2022 Q4	$12.5M	Buy	243,231 +32,256	+15%	+$1.55M	0.77%	19
2022 Q3	$9.23M	Buy	+210,975	New	+$10.3M	0.7%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Partners II's PFE Position: Q3 2023 in Review

Advisor Partners II reduced its Pfizer (PFE) stake by 3.7% in Q3 2023, selling an estimated $287K and leaving 211,624 shares worth $7.02M. The position accounts for 0.28% of the portfolio, ranked #54.

Advisor Partners II first reported a position in PFE in Q3 2022 and has held it in 5 quarters since. The position peaked at $12.5M in Q4 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Advisor Partners II held 211,624 shares of Pfizer worth $7.02M as of Q3 2023.
Advisor Partners II sold 8,122 Pfizer shares in Q3 2023, an estimated $287K.
Pfizer made up 0.28% of Advisor Partners II's portfolio in Q3 2023, its #54 holding.
Advisor Partners II first reported a position in Pfizer in Q3 2022 and has held it in 5 quarters since.
Advisor Partners II's Pfizer position peaked at $12.5M in Q4 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.